1. Home
  2. PEW vs ACRV Comparison

PEW vs ACRV Comparison

Compare PEW & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GrabAGun Digital Holdings Inc.

PEW

GrabAGun Digital Holdings Inc.

HOLD

Current Price

$2.50

Market Cap

72.6M

ML Signal

HOLD

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

HOLD

Current Price

$1.51

Market Cap

68.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEW
ACRV
Founded
2007
2018
Country
United States
United States
Employees
50
N/A
Industry
Other Specialty Stores
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.6M
68.5M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
PEW
ACRV
Price
$2.50
$1.51
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$6.75
$11.67
AVG Volume (30 Days)
895.6K
460.7K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
15.13
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.25
N/A
Revenue Next Year
$7.96
$568.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$1.20
52 Week High
$7.19
$3.56

Technical Indicators

Market Signals
Indicator
PEW
ACRV
Relative Strength Index (RSI) 46.65 32.65
Support Level $2.25 $1.38
Resistance Level $3.22 $2.20
Average True Range (ATR) 0.13 0.12
MACD -0.01 -0.05
Stochastic Oscillator 22.91 2.68

Price Performance

Historical Comparison
PEW
ACRV

About PEW GrabAGun Digital Holdings Inc.

GrabAGun Digital Holdings Inc is a multi-brand eCommerce retailer of firearms, ammunition and related accessories. The Company's firearm products are ordered and paid for by customers online through the Company's eCommerce site and mobile app and are delivered to them on-premises through their choice of federal firearm licensed dealers nationwide. The Company's network of localized firearm dealers perform background checks on firearms purchasers and complete sales forms as mandated by federal and state firearm regulations.

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.

Share on Social Networks: